Walgreens Boots Alliance Inc (NASDAQ:WBA) insider Stefano Pessina purchased 98,858 shares of the firm’s stock in a transaction that occurred on Monday, January 15th. The stock was bought at an average cost of $76.07 per share, for a total transaction of $7,520,128.06. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink.
Walgreens Boots Alliance Inc (NASDAQ WBA) opened at $75.78 on Thursday. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.96 and a quick ratio of 0.47. The company has a market capitalization of $75,050.00, a price-to-earnings ratio of 20.93, a price-to-earnings-growth ratio of 1.29 and a beta of 1.22. Walgreens Boots Alliance Inc has a one year low of $63.82 and a one year high of $88.00.
Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share for the quarter, topping analysts’ consensus estimates of $1.27 by $0.01. The company had revenue of $30.74 billion during the quarter, compared to the consensus estimate of $30.39 billion. Walgreens Boots Alliance had a return on equity of 19.15% and a net margin of 3.19%. The firm’s quarterly revenue was up 7.9% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.10 earnings per share. sell-side analysts expect that Walgreens Boots Alliance Inc will post 5.7 EPS for the current year.
Several analysts recently commented on the company. Zacks Investment Research raised Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $82.00 price target on the stock in a research note on Saturday, January 13th. BidaskClub raised Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research note on Wednesday, January 10th. Needham & Company LLC reaffirmed a “buy” rating and issued a $88.00 price target (up previously from $86.00) on shares of Walgreens Boots Alliance in a research note on Wednesday, January 10th. Pivotal Research set a $73.00 price target on Walgreens Boots Alliance and gave the company a “hold” rating in a research note on Friday, January 5th. Finally, ValuEngine raised Walgreens Boots Alliance from a “hold” rating to a “buy” rating in a research note on Thursday, January 4th. Nine investment analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $86.20.
Hedge funds have recently added to or reduced their stakes in the company. Heritage Investors Management Corp bought a new stake in Walgreens Boots Alliance in the second quarter valued at about $262,000. Capital Investment Advisors LLC increased its holdings in Walgreens Boots Alliance by 7.6% in the second quarter. Capital Investment Advisors LLC now owns 6,027 shares of the pharmacy operator’s stock valued at $472,000 after purchasing an additional 428 shares during the last quarter. Fulton Bank N.A. increased its holdings in Walgreens Boots Alliance by 37.3% in the second quarter. Fulton Bank N.A. now owns 4,849 shares of the pharmacy operator’s stock valued at $380,000 after purchasing an additional 1,318 shares during the last quarter. Tompkins Financial Corp increased its holdings in Walgreens Boots Alliance by 0.4% in the second quarter. Tompkins Financial Corp now owns 39,955 shares of the pharmacy operator’s stock valued at $3,128,000 after purchasing an additional 162 shares during the last quarter. Finally, Family Legacy Inc. increased its holdings in Walgreens Boots Alliance by 3.1% in the second quarter. Family Legacy Inc. now owns 9,537 shares of the pharmacy operator’s stock valued at $747,000 after purchasing an additional 285 shares during the last quarter. Institutional investors own 61.20% of the company’s stock.
TRADEMARK VIOLATION NOTICE: “Walgreens Boots Alliance Inc (WBA) Insider Stefano Pessina Purchases 98,858 Shares” was first published by Community Financial News and is owned by of Community Financial News. If you are reading this news story on another website, it was stolen and reposted in violation of U.S. and international trademark and copyright law. The legal version of this news story can be read at https://www.com-unik.info/2018/01/18/walgreens-boots-alliance-inc-wba-insider-stefano-pessina-purchases-98858-shares.html.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.